We hope you will join us for our popular 19th Annual Scientific Meeting which we are delighted is able to return to The King's Fund, London, this year.
The meeting will promote and share academic and clinical interest across the cardiorenal multidisciplinary team. The focus of this year’s meeting will be to share the latest advances in research, treatment and prevention of heart and kidney diseases.
State-of-the-art presentations with interactive discussion and case-based learning will be offered, with time to network in the breaks and visit our exhibition. We are looking forward to seeing everyone there.
Places for healthcare professionals are limited and will go fast!
Is it for me?
Our meetings are aimed at healthcare professionals and are aimed at anyone treating the cardiorenal patient particularly those working in heart failure, cardiology, nephrology, diabetes, lipids, endocrinology, care of the elderly, general medicine, general practice, clinical pharmacy and allied disciplines. Feedback from past delegates has been very positive with 100% of delegates at our last meeting saying the meeting was clinically excellent to good.
Accreditation
The Cardiorenal Forum will award 5 CPD credits for this meeting.
Academic endorsement
Last year’s meeting was endorsed by The British Society for Heart Failure (BSH), the Irish Nephrology Society, Kidney Disease Improving Global Outcomes (KDIGO), and the UK Kidney Association (UKKA), from whom we will be seeking academic endorsement for this year's meeting.
Funding
This independent meeting will be supported and funded by pharmaceutical companies.
Registration fee
Our registration fees are subsidised. Early bird fees to include lunch and refreshments throughout the day are:
£110 doctors (SpR and consultant grades), £75 concessions (nurses, trainees, allied HCPs), £300 commercial organisations. All fees are inclusive of VAT.
Travel grants
We are pleased to offer a limited number of travel grants for 2024. Travel grants are for the concessions rate only (nurses, trainees, HCPs). The grant, up to a maximum of £100 for those living more than 100 miles away, or up to £50 for those living less than 100 miles away but outside the M25, will cover travel and any remaining allocation will be allocated towards a partial reimbursement of your registration fee. Travel must be by public transport only – train, bus, tube - using advance purchase tickets, standard fare.
Applications must be in by 29th July 2024 and successful applicants will be notified week commencing 5th August 2024. For further information click here.
Chair: Professor Gerry McCann, NIHR Research Professor, (Experimental Medicine) and Professor of Cardiac Imaging, University of Leicester | |
09:30 | Introduction |
09.35 | What is HFpEF, and how do we manage it? Professor Christopher Miller, Professor of Cardiovascular Medicine, NIHR Advanced Fellow and Honorary Consultant Cardiologist, Division of Cardiovascular Sciences, University of Manchester |
09.55 | New lipid treatment options in cardiometabolic diseases Dr Saleem Ansari, Registrar, Division of Diabetes, Endocrinology and Metabolism, Imperial College London; UK Lipids and Cardiovascular Risk Service, Department of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London |
10.15 | Discussion |
Chair: Professor Paul Kalra, Consultant Cardiologist, Portsmouth Hospitals NHS Trust, Portsmouth | |
10:25 | Resistant hypertension – addressing mechanisms, medical and other treatments Dr David New, Consultant Nephrologist, Salford Royal Foundation Trust |
10:45 | Cardiorenal anaemia – assessing options for treatments Dr Noémi Roy, Associate Professor of Molecular Haematology; Consultant Haematologist, Oxford University Hospitals NHS Foundation Trust, Oxford |
11.05 | Discussion |
11:15 | Coffee break / Exhibition and networking |
Chairs: Dr Julianne Mogford, Palliative Care Physician, Royal Trinity Hospice, London, and Professor Philip Kalra, Consultant Nephrologist, Salford Royal NHS Foundation Trust; Professor of Renal Medicine, University of Manchester | |
11:45 | Caring for the patient with end-stage heart failure – a case study Dr Alexandra Abel, GP Registrar in Rehabilitation Medicine, and Honorary Lecturer, Hull York Medical School, Hull |
12:05 | Immunoglobulin A (IgA) nephropathy Dr Kaitlin Mayne, Nephrology Registrar, Glasgow Renal & Transplant Unit, Queen Elizabeth University Hospital, Glasgow |
12.25 | Discussion |
13:15 | Lunch break / Exhibition and networking |
Chair: Ms Carys Barton, Heart Failure Nurse Consultant, Imperial NHS Foundation Trust (TBC) | |
14:15 | Cardiac amyloidosis – advances in diagnosis and treatment Professor Julian Gillmore, Professor of Medicine, University College London; Clinical Lead for ATTR Amyloidosis, UK National Amyloidosis Centre, London |
14.40 | Discussion |
Chairs: Professor Derek Yellon, Director, Hatter Cardiovascular Research Institute, UCL, London, and Dr David Mulcahy, Consultant Cardiologist, Blackrock Health, Hermitage Clinic, Dublin | |
14:45 | Cardiac trials Dr Geraint Morton, Consultant Cardiologist, Portsmouth Hospitals NHS Trust |
15:05 | Renal trials Dr David Lappin, Consultant Nephrologist, Galway University Hospitals; Honorary Personal Professor of Medicine, University of Galway |
15.25 | Discussion |
15:35 | Tea break / Exhibition and networking |
Chair: Dr Sarah Birkhoelzer, Cardiology Registrar and Clinical Research Fellow, University of Oxford | |
16:00 | Leukaemia and its treatment – cardiovascular sequelae Dr Renata Walewska, Consultant Haematologist, Royal Bournemouth Hospital; Chair, UK CLL Forum |
16.25 | Discussion |
Chairs: Professor Smeeta Sinha, Consultant Nephrologist, Salford Royal Hospital; National Clinical Director for Renal Services; and Ms Kathrine Parker, Specialist Renal Pharmacist, Manchester University NHSFT | |
16:30 | Prevalence of diabetic kidney disease in the UK – management in primary care Dr Stuart Stewart, GP and Research Fellow, Donal O’Donoghue Renal Research Centre (Northern Care Alliance), and Centre for Primary Care & Health Services Research and the Division of Cardiovascular Sciences, University of Manchester |
16:50 | Modern CKD care – a GP perspective and community challenges Dr Pierina Kapur, GP Partner, Chapel Group Medical Centre; Clinical Director, Eccles and Irlam Primary Care Network, Salford |
17.10 | Discussion |
17:20 | Meeting close |
Dr Alexandra Abel GP Registrar in Rehabilitation Medicine, and Honorary Lecturer, Hull York Medical School, Hull |
||
Dr Saleem Ansari Registrar, Division of Diabetes, Endocrinology and Metabolism, Imperial College London; UK Lipids and Cardiovascular Risk Service, Department of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London |
||
Ms Carys Barton Heart Failure Nurse Consultant, Imperial NHS Foundation Trust (TBC) |
||
Dr Sarah Birkhoelzer Cardiology Registrar and Clinical Research Fellow, University of Oxford |
||
Professor Julian Gilmore Professor of Medicine, University College London; Clinical Lead for ATTR Amyloidosis, UK National Amyloidosis Centre, London |
||
Professor Paul Kalra Consultant Cardiologist, Portsmouth Hospitals NHS Trust, Portsmouth |
||
Professor Philip Kalra Consultant Nephrologist, Salford Royal NHS Foundation Trust; Professor of Renal Medicine, University of Manchester |
||
Dr Pierina Kapur GP Partner, Chapel Group Medical Centre; Clinical Director, Eccles and Irlam Primary Care Network, Salford |
||
Dr David Lappin Consultant Nephrologist, Galway University Hospitals; Honorary Personal Professor of Medicine, University of Galway |
||
Dr Kaitlin Mayne Nephrology Registrar, Glasgow Renal & Transplant Unit, Queen Elizabeth University Hospital, Glasgow |
||
Professor Gerry McCann NIHR Research Professor, (Experimental Medicine) and Professor of Cardiac Imaging, University of Leicester |
Professor Christopher Miller Professor of Cardiovascular Medicine, NIHR Advanced Fellow and Honorary Consultant Cardiologist , Division of Cardiovascular Sciences, University of Manchester |
||
Dr Julianne Mogford Palliative Care Physician, Royal Trinity Hospice, London |
||
Dr Geraint Morton Consultant Cardiologist, Portsmouth Hospitals NHS Trust |
||
Dr David Mulcahy Consultant Cardiologist, Blackrock Health, Hermitage Clinic, Dublin |
||
Dr David New Consultant Nephrologist, Salford Royal Foundation Trust |
||
Ms Kathrine Parker Specialist Renal Pharmacist, Manchester University NHSFT |
||
Dr Noémi Roy Associate Professor of Molecular Haematology; Consultant Haematologist, Oxford University Hospitals NHS Foundation Trust, Oxford |
||
Professor Smeeta Sinha Consultant Nephrologist, Salford Royal Hospital; National Clinical Director for Renal Services |
||
Dr Renata Walewska Consultant Haematologist, Royal Bournemouth Hospital; Chair, UK CLL Forum |
||
Professor Derek Yellon Director, Hatter Cardiovascular Research Institute, UCL, London |